Latest news
First Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMTIovance Biotherapeutics Reports Record Second Quarter 2026 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:01:00 GMTWhy Germans & Austrians Choose Sheba for TIL Therapy & Melanoma Care - healthcare-in-europe.comhealthcare-in-europe.com · Wed, 05 Aug 2026 22:04:14 GMTObsidian raises USD 350m to advance engineered TIL therapy into registration-enabling melanoma trial - AllSciAllSci · Mon, 03 Aug 2026 17:35:22 GMTTIL Cell Therapy in HIV Positive Patient With Metastatic Melanoma: Case Report - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 12:48:28 GMTNew treatment for advanced melanoma uses tumor to fight the disease - CBS NewsCBS News · Mon, 03 Aug 2026 01:09:00 GMTFDA Advisory Committee Backs RP1 for Advanced Melanoma - Cure TodayCure Today · Sun, 02 Aug 2026 14:37:01 GMTSheba Is Giving Europeans Greater Access to TIL Therapy for Metastatic Melanoma - healthcare-in-europe.comhealthcare-in-europe.com · Fri, 31 Jul 2026 22:02:02 GMT